Skip to main content
. 2008 Feb;4(1):87–97. doi: 10.2147/tcrm.s1109

Table 2.

Topical imiquimod in the treatment of BCCs: indications

  • Extensive, and/or multifocal, and/or multiple tumours

  • Cosmetically sensitive anatomic sites (face)

  • History of hypertrophic scarring and/or keloids

  • Surgical risk factors (eg, age, associated disorders)

  • Psychological condition of the patient

  • Patient refusal to undergo surgical procedures